HomeUSASOSV Closes $306M Deep Tech Fund

SOSV Closes $306M Deep Tech Fund

SOSV logo

SOSV, a Princeton, NJ-based multi-stage deep tech venture investor, announced the close of SOSV V fund, at $306M.

Limited partners included corporates, sovereign wealth funds, institutional investors, and private family offices around the world.

The fund will focus on deep tech startups in human and planetary health, with an emphasis on decarbonization and re-industrialization, even as SOSV continues to make investments in health ranging from therapeutics to medical devices.

Led by Sean O’Sullivan, founding and managing general partner, SOSV is a multi-stage deep tech venture investor focused on “human and planetary health”. It operates the startup development programs IndieBio, with facilities in New York City and San Francisco, and HAX, which is headquartered in Newark, New Jersey, with a satellite office in Tokyo. The SOSV ecosystem spans the globe, with 800+ startups operating in 40 countries.

The firm invests starting at pre-seed, when companies join its HAX and IndieBio development programs, and continues through series seed, A, and later stages, resulting in about 200 investments per year. It operates startup program facilities in New York City, Newark, and San Francisco and graduates about 80 startups a year.

SOSV has invested over $30m in facilities and equipment to help deep tech founders develop and de-risk their technologies. In the past 18 months, the firm has opened two new spaces—IndieBio New York at 7 Penn Plaza and HAX in Newark, NJ—with $25M in grants each from Empire State Development (ESD) and New Jersey Economic Development Authority (NJEDA), and also relocated and expanded the IndieBio San Francisco location.